New data to address evidence gaps in access to medicines
LCP Health Analytics is partnering with COTA to explore how US real-world data (RWD) can support health technology assessments (HTA) in the United Kingdom (UK) and European...
Scottish Brain Sciences opens new Alzheimer’s clinical research centre
Scottish Brain Sciences (SBS), a leading clinical research organisation dedicated to transforming the early detection and treatment of Alzheimer’s disease and other neurodegenerative conditions,...
MHRA broadens Pfizer Abrysvo licence
This expansion from the current 60 years plus licence makes Pfizer’s RSV vaccine the only one licensed in the UK for adults over 18 years...
Pharma Press
Bringing you the latest pharmaceutical industry news, views and opinion.
Drug Discovery & Development (DDD) is part of the Pharma Press portfolio and welcomes readers,...
Relief Therapeutics acquisition announced
Relief Therapeutics has announced the execution of a binding term sheet for a proposed business combination with NeuroX Group SA, a privately held company...
American Biomanufacturing Summit 2026
14-15 April 2026 | Hyatt Regency San Francisco Airport - San Francisco, CA, USA
The American Biomanufacturing Summit will serve as a key meeting point...
New money from new investors for supply chain leveraging
Supply chain leveraging is being financed co-led by new investors Sofinnova Investments and B Capital, along with an existing investor with continued support from F-Prime,...
Global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2 fixed
To answer to the global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2 by Natix, which is a leading European distributor of natural performant bioactives...
Additional $5.1m to progress ABX-01 lead compound to first in human clinical...
Centauri Therapeutics Limited has announced that Carb-X (Combating antibiotic-resistant bacteria biopharmaceutical accelerator) has provided an additional $5.1m in funding for the development of their...
Response to misleading antidepressant withdrawal study and media campaign
The Beyond Pills All-Party Parliamentary Group has expressed serious concern over the publication and promotion of a recent study claiming that antidepressant withdrawal is...